PerfuseCell Cronus A/S: Financial statements 2016
CVR: 31606810
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
PerfuseCell Cronus A/S (CVR 31606810) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -180 the year before. Equity in the 2016 report amounted to DKK 14,327. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 14,327
- Total Assets
- DKK 14,327
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 0 | 0 | 0 | 14 t. | - |
| 2015 | 0 | 0 | -180 | 14 t. | - |
| 2014 | 0 | 0 | -3 t. | 15 t. | - |
| 2013 | 3 t. | 3 t. | -631 | 17 t. | - |
| 2012 | - | -45 t. | -45 t. | 18 t. | - |
Official annual report
Find more companies like PerfuseCell Cronus A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
PerfuseCell Cronus A/S has published its annual report for 2015. Revenue came to DKK 0, and the net result was DKK -180.
About PerfuseCell Cronus A/S
PerfuseCell Cronus A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2008. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named PerfuseCell A/S and PumpCell A/S. The management consists of Per Stobbe. The board consists of August Kisling Stobbe, Flemming Petersen and Per Stobbe. The company is owned by Stobbe GmbH. In 2025, the company reported a gross profit of DKK 20,467 and a net result of DKK 23,973 compared with DKK 2,216 the year before. Equity in the 2025 report amounted to DKK 1,070,836.